This guideline provides risk-stratified recommendations about when to add SGLT-2 inhibitors or GLP-1 receptor agonists to existing treatment for adults with type 2 diabetes
The US proposal to waive patents has been hailed as a much needed boost for global equity, but obstacles remain
The spotlight on genomic sequencing has highlighted inequalities in global capacity
Will Sputnik V be authorised by a major regulator? And why have neither The Lancet nor the Sputnik team provided requested data after publication?
New study finds a link, but vaccination remains overwhelmingly the safest option
Richer nations have a vital role to play in ensuring equity of access to covid-19 vaccines around the world, say Maggie Rae and Helen Stokes-Lampard
Any isolationism or exceptionalism we sow today will reap a future harvest of premature death and worse health, writes Kamran Abbasi
Surajit Nundy describes the scene working in an intensive care unit in Delhi